Lixisenatide Subcutaneous and Loteprednol and tobramycin ophthalmic
Determining the interaction of Lixisenatide Subcutaneous and Loteprednol and tobramycin ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
Generic Name: loteprednol / tobramycin ophthalmic
Brand name: Zylet
Synonyms: Loteprednol and tobramycin (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lixisenatide Subcutaneous-Loteprednol Etabonate
- Lixisenatide Subcutaneous-Loteprednol Eye Drops
- Lixisenatide Subcutaneous-Loteprednol Eye Drops 0.2%
- Lixisenatide Subcutaneous-Loteprednol Eye Drops 0.5% and 1%
- Lixisenatide Subcutaneous-Loteprednol Eye Gel
- Lixisenatide Subcutaneous-Loteprednol Eye Ointment
- Loteprednol and tobramycin ophthalmic-Lixtraxen Injection
- Loteprednol and tobramycin ophthalmic-LMD
- Loteprednol and tobramycin ophthalmic-LMD Injection
- Loteprednol and tobramycin ophthalmic-LMX 4 Topical application
- Loteprednol and tobramycin ophthalmic-LMX 5
- Loteprednol and tobramycin ophthalmic-LMX 5 Topical application